Cal-Maine vs. Tyson: Which Protein Stock Packs a Stronger Punch Now?

Cal-Maine Foods (CALM) reported robust Q3 FY25 results with EPS of $10.38 and revenue up 102%, driven by strong egg pricing and volumes, but faces near-term pressure from easing egg prices and declining FY26 earnings estimates. In contrast, Tyson Foods (TSN) posted a 48% rise in Q2 FY25 EPS to $0.92, propelled by efficiency gains and lower costs in its Chicken segment despite broader volume declines. While CALM's stock has significantly outperformed over the past year, Tyson is deemed the more compelling investment due to its cheaper 13.23x forward valuation, upward-trending earnings outlook, and improved operational performance, contrasting with Cal-Maine's higher 17.79x valuation and a 'Sell' rating.

Analysis

Cal-Maine Foods (CALM) and Tyson Foods (TSN) present divergent investment profiles despite both operating in the protein sector. Cal-Maine reported an exceptional third quarter, with earnings per share of $10.38 and a 102% year-over-year revenue surge, driven almost entirely by record-high egg prices resulting from avian flu (HPAI) supply disruptions. This was amplified by a 9.6% reduction in feed costs. However, this performance is unlikely to be sustained, as egg prices are already easing. Analyst consensus reflects this, projecting a 74.9% earnings decline for fiscal 2026, with estimates for both FY25 and FY26 trending downwards. In contrast, Tyson Foods demonstrated operational improvement, with a 48% rise in Q2 adjusted EPS to $0.92 despite flat revenue. The strength was concentrated in its Chicken segment, where adjusted operating income nearly doubled due to efficiency gains and lower feed costs, offsetting persistent weakness in the Beef segment from an unfavorable cattle cycle. Crucially, Tyson's earnings estimates for fiscal 2025 and 2026 are trending upward. This fundamental momentum, combined with a lower forward P/E multiple of 13.23x versus Cal-Maine's 17.79x, positions Tyson more favorably from a forward-looking perspective.

Key Decisions for Investors

• Investors should be cautious with Cal-Maine, as its current earnings are at a cyclical peak driven by anomalous egg prices, and the stock's 67% appreciation may not be justified given the forecasted 74.9% earnings decline in fiscal 2026.
• Tyson Foods appears to be a more compelling investment due to its attractive valuation at a 13.23x forward P/E, upward-trending earnings estimates, and demonstrated operational turn-around in its critical Chicken segment.
• Consider the relative value trade of reducing exposure to the high-valuation, cyclically-peaking CALM in favor of the fundamentally improving, lower-valuation TSN.
• Closely monitor commodity prices, particularly the normalization of egg prices for Cal-Maine's profitability and cattle prices for Tyson's Beef segment challenges, as these are key determinants of future earnings for both companies.